HALO logo
halo search icon
20/20 Biolabs, Inc.

US$1.29

Price Change Indicator
-0.0501 (-3.739%)
20/20 Biolabs, Inc.
AIDX · NAS

20/20 Biolabs, Inc.

Start Trading AIDX for Free

US$1.29

Price Arrow-0.0501 (-3.739%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHammer Bearish (Realtime)Hammer Bullish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

20/20 Biolabs, Inc. Overview

AIDX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About AIDX

icon

Website

20/20 Biolabs, Inc.

icon

Telephone

1.240.453.6339

icon

Address

Suite 235, 15810 Gaither Road, Gaithersburg, MD 20877

Description

20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in May 2000 and is headquartered in Gaithersburg, MD.

AIDX Price Chart

Key Stats

Market Cap

US$14.04M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.26 - 50

Trade Value (12mth)

US$48,726.00

1 week

0.01%

1 month

-21.86%

YTD

-94.38%

1 year

0%

All time high

50.00

Key Fundamentals

EPS 3 yr Growth

-177.80%

EBITDA Margin

-159.10%

Operating Cashflow

-$2m

Free Cash Flow Return

-116.50%

ROIC

-226.80%

Interest Coverage

-20.80

Quick Ratio

0.60

Other Data

Shares Outstanding (Fully Diluted)

10m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AIDX Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
21 May 26

AIDX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.34-1.16-0.36locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.34-1.16-0.36locklocklock
Growth
 %locklocklocklock-391.313.469.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of 20/20 Biolabs, Inc. (AIDX:NAS)?
Halo FAQ
The current share price of 20/20 Biolabs, Inc. (AIDX:NAS) is USD$1.29.
What is the 52-week high share price for 20/20 Biolabs, Inc. (AIDX:NAS)?
Halo FAQ
The 52-week high share price for 20/20 Biolabs, Inc. (AIDX:NAS) is USD$50.00.
What is the 52-week low share price for 20/20 Biolabs, Inc. (AIDX:NAS)?
Halo FAQ
The 52-week low share price for 20/20 Biolabs, Inc. (AIDX:NAS) is USD$1.26.
What is the dividend yield for 20/20 Biolabs, Inc. (AIDX:NAS)?
Halo FAQ
20/20 Biolabs, Inc. (AIDX:NAS) does not pay a dividend.
What was 20/20 Biolabs, Inc. (AIDX:NAS) last dividend payment?
Halo FAQ
20/20 Biolabs, Inc. (AIDX:NAS) does not pay a dividend.
What is the franking level for 20/20 Biolabs, Inc. (AIDX:NAS)?
Halo FAQ
20/20 Biolabs, Inc. (AIDX:NAS) has a franking level of 0.00%.
In which sector is 20/20 Biolabs, Inc. (AIDX:NAS) classified?
Halo FAQ
20/20 Biolabs, Inc. (AIDX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial